Dr. John P. Delisio, MD

Dr. Delisio practices at Virginia Urology Center in Richmond, Virginia.

Dr. Delisio's NPI, 1255397642, was assigned on April 25, 2006. Dr. Delisio graduated from New York Medical College in 1996. Dr. Delisio holds Virginia license 0101 057086.

Dr. Delisio's primary practice is Virginia Urology Center, at 9101 Stony Point Dr, Richmond, VA 23235 in Chesterfield County. The practice phone is (804) 330-9105.

Dr. Delisio's primary practice is Virginia Urology Center in Richmond, Virginia. Dr. Delisio is also affiliated with Bon Secours St. Mary's Hospital. The medical group on file is Virginia Urology. Dmand AI also links Dr. Delisio to 4 more hospitals and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Delisio practices, 6 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Delisio's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Delisio is board certified in urology by the American Board of Urology. Dmand AI has Dr. Delisio's licenses on file in 4 states: Virginia, New York, District of Columbia and Maryland.

Dmand AI lists bladder disease, enlarged prostate, erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease, pelvic prolapse and prostate cancer among the conditions Dr. Delisio treats.

CMS data shows 7,422 Medicare services from Dr. Delisio across 30 procedure codes in 2024, for 984 Medicare patients. Medicare paid $252,576 for them.

CMS counts 984 Medicare patients who saw Dr. Delisio in 2024. The largest group is 65 to 74, with 432 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 3% are also on Medicaid. Their average risk score is 1.22, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Delisio's median patient age at 74, with 24% women.

In 2024, Dr. Delisio wrote 2,172 Medicare Part D claims for 540 patients. 87% of them were for generic drugs. CMS names the drug for 2,014 of them, across 21 drugs with 11 or more claims each, at $2,321,482 in total drug cost. In 2023, CMS named 1,893 claims across 24 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 77 out of 100 for Dr. Delisio for performance year 2024, reported as part of a group. Dr. Delisio accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Delisio as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Delisio. The most frequent topics are Chromosome Mapping and Chromosomes, Human, Pair 3.

CMS Open Payments shows 1,323 general payments to Dr. Delisio from 69 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 63% of the total. Edap Technomed Inc paid the most, $13,397.

Dr. Delisio graduated from New York Medical College in 1996.

Dr. Delisio is in network with 17 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.